angiotensin converting enzyme inhibitors (ACEI), ramipril
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 1999 Jul 31;354(9176):359-64 Randomized Controlled Trial
IN kidney disease, chronic, non diabetic The Use of
angiotensin converting enzyme inhibitors (ACEI), ramipril
As Treatment, Chronic
Is better Than
placebo plus conventional antihypertensive therapy
To reduce progression to end-stage renal failure: 9% ACEI VS 20% controls